These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5083174)

  • 1. Thyroid-imipramine clinical and chemical interaction: evidence for a receptor deficit in depression.
    Prange AJ; Wilson IC; Knox AE; McClane TK; Breese GR; Martin BR; Alltop LB; Lipton MA
    J Psychiatr Res; 1972 Sep; 9(3):187-205. PubMed ID: 5083174
    [No Abstract]   [Full Text] [Related]  

  • 2. Catecholamine metabolism, depressive illness, and drug response.
    Maas JW; Fawcett JA; Dekirmenjian H
    Arch Gen Psychiatry; 1972 Mar; 26(3):252-62. PubMed ID: 4551050
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications.
    Prange AJ; Wilson IC; Knox A; McClane TK; Lipton MA
    Am J Psychiatry; 1970 Aug; 127(2):191-9. PubMed ID: 5473147
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline.
    Schildkraut JJ; Draskoczy PR; Gershon ES; Reich P; Grab EL
    J Psychiatr Res; 1972 Sep; 9(3):173-85. PubMed ID: 5083173
    [No Abstract]   [Full Text] [Related]  

  • 5. MHPG excretion by patients with affective disorders.
    Maas JW; Dekirmenjian H; Fawcett JA
    Int Pharmacopsychiatry; 1974; 9(1):14-26. PubMed ID: 4600126
    [No Abstract]   [Full Text] [Related]  

  • 6. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Densitometric determination of catecholamine metabolites and 5-hydroxy-indoleacetic acid after two-dimensional thin-layer chromatography on cellulose.
    Breebaart K; Haan AM; Wadman SK
    Clin Chim Acta; 1972 Mar; 37():157-64. PubMed ID: 5022078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of the biogenic amines during therapy with imipramine].
    Bruno A; Cumer Bruno S
    Riv Neurobiol; 1968; 14(4):555-63. PubMed ID: 5738407
    [No Abstract]   [Full Text] [Related]  

  • 9. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
    Schildkraut JJ
    Am J Psychiatry; 1973 Jun; 130(6):695-9. PubMed ID: 4701961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 1. Clinical studies on urinary metanephrine and normetanephrine in healthy subjects and patients with thyroid diseases].
    Shimbo S
    Naika Hokan; 1968 Sep; 15(9):287-98. PubMed ID: 5752085
    [No Abstract]   [Full Text] [Related]  

  • 11. Affective disorders and norepinephrine pharmacology.
    Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
    Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Routine gas chromatographic analysis of metanephrine/normetanephrine, 3-methoxy-4-hydroxyphenylglycol and vanilmandelic acid in urine as TMS-vanillin or -vanillyl alcohol].
    Schwedt G; Blödorn A; Bussemas HH
    Clin Chim Acta; 1975 Dec; 65(3):309-18. PubMed ID: 1204221
    [No Abstract]   [Full Text] [Related]  

  • 13. Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants.
    Fawcett J; Maas JW
    Arch Gen Psychiatry; 1972 Mar; 26(3):246-51. PubMed ID: 5059634
    [No Abstract]   [Full Text] [Related]  

  • 14. Normetanephrine excretion and affective state in depressed patients treated with imipramine.
    Schildkraut JJ; Green R; Gordon EK; Durell J
    Am J Psychiatry; 1966 Dec; 123(6):690-700. PubMed ID: 5333088
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
    Krzyzowski J; Lewicka-Wysocka H; Lukaszewska B; Marcjan K; Pacyna M; Pietruszewska I; Roguska E; Stencka K
    Pol Tyg Lek; 1981 Mar; 36(11):417-21. PubMed ID: 6167972
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyroid hormone in the treatment of depression.
    Slusher N
    South Med J; 1975 Aug; 68(8):1035-6. PubMed ID: 808858
    [No Abstract]   [Full Text] [Related]  

  • 18. Triiodothyronine, imipramine, and depression.
    Steiner M
    Am J Psychiatry; 1980 Mar; 137(3):383-4. PubMed ID: 7356079
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of imipramine antidepressant activity by thyroid hormone.
    Prange AJ; Wilson IC; Rabon AM; Lipton MA
    Am J Psychiatry; 1969 Oct; 126(4):457-69. PubMed ID: 4185164
    [No Abstract]   [Full Text] [Related]  

  • 20. Monoamine precursors in the treatment of depression.
    Carroll BJ
    Clin Pharmacol Ther; 1971; 12(5):743-61. PubMed ID: 4936139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.